Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. - Wikidata - awgldk - TriplyDB

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.

http://www.wikidata.org/entity/Q35167137

about

Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes Vaccines for preventing influenza in healthy adults Maternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptance The Global Influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenza Maternal immunization The pandemic influenza A (H1N1) 2009 vaccine does not increase the mortality rate of idiopathic interstitial pneumonia: a matched case-control study.Risk management of seasonal influenza during pregnancy: current perspectives.Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.Influenza virus infection in pregnancy: a review.Maternal vaccination for the prevention of influenza: current status and hopes for the future.Publication delay of randomized trials on 2009 influenza A (H1N1) vaccination.Immunogenicity of trivalent inactivated influenza vaccination received during pregnancy or postpartum Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons Influenza in pregnancy.Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trial Rapid research response to the 2009 A(H1N1)pdm09 influenza pandemic (Revised).Optimizing benefits of influenza virus vaccination during pregnancy: potential behavioral risk factors and interventions.The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014 The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.Influenza and pregnancy: a review of the literature from India Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy.Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine Pregnancy Does Not Attenuate the Antibody or Plasmablast Response to Inactivated Influenza Vaccine Benefits of influenza vaccination during pregnancy for pregnant women.Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants A systematic review of ethical issues in vaccine studies involving pregnant women.Serum proinflammatory cytokine responses to influenza virus vaccine among women during pregnancy versus non-pregnancy.Benefits to mother and child of influenza vaccination during pregnancy.Efficacy and effectiveness of maternal influenza vaccination during pregnancy: a review of the evidence.Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers.Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.Pregnancy modifies the antibody response to trivalent influenza immunization.Influenza immunization policies: Which could be the main reasons for differences among countries?Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy.Impact of timing of influenza vaccination in pregnancy on transplacental antibody transfer, influenza incidence and birth outcomes; a randomized trial in rural Nepal.

P2860

Q24187227-55693852-25F9-471C-842C-DF233A48FFE5 Q24197955-397A0FB6-B73D-4068-A206-91ACB5D14E56 Q26779482-71D4C10B-CD0E-4099-9DFA-87DAAF6153E3 Q26800534-51AE2D48-C7C7-41E0-8A74-6B23BD463DA1 Q26853746-93E677F4-D333-424A-BD8D-AFC81C415F25 Q30359671-E203C7FF-E81F-448A-A727-FDF5D5494D1B Q30365596-2EA68120-DC24-4262-B680-FC26C10BD1DA Q30374546-39431300-B1EF-46A1-B4F0-0B5995B94EB5 Q30374989-32935A50-3C41-4F99-90B3-65EE8BC4AB07 Q30386781-6C0C9478-70A2-4705-87CE-C8855D44D256 Q30410554-5C589C0F-8729-4DCD-8C41-6931B21D16DE Q30413366-55BD87EB-D907-4A61-8D8D-72C8530F4580 Q30419062-97E93035-B2ED-4A0F-8A2A-9776DFC1FBF9 Q30423910-885DBD5B-2435-45AA-8096-FA244C5BB0B6 Q30426754-CB225CC7-757B-4F71-A620-396CC8AC3281 Q30430043-FE32F7FD-68C8-47FD-A520-EDECAF78505B Q30430120-81BAA0DB-C7A2-48F1-B622-742145135D8B Q33705792-1620B134-1377-44FE-9031-C582CE0C61A9 Q34576732-87657631-0EA2-4745-9BF9-690D841BED83 Q34769368-13333DA7-9C85-425B-A139-14815BF46F9B Q35163782-D6B06494-E56A-4E4A-BDF7-50C655302821 Q35682690-7B0B57AD-2E19-46A0-A8E5-788514CEB8AC Q35866636-8A5CC5F1-CF2B-40E6-B959-666701455278 Q35993484-4DDC435C-9F32-4BAA-AB98-6EA4CB15F9F8 Q36003849-52B5C1D4-A512-4E6C-B410-A104FBC49B2B Q36306940-2E7D5C72-8C54-4C46-BCAA-4B659B6697AF Q37197059-DBDD8405-D25A-4D35-9E77-32D14B210967 Q37425640-53BAC7AE-A339-4FFE-86A9-1B5885A75776 Q37976536-F10016D6-6F06-45D4-B20B-38F49D3D4873 Q38165876-55155EF3-87E5-44F3-B679-516A9EFEB267 Q38671897-D1A12755-572B-4349-8EF5-ED6DE0B48688 Q40094268-FEC82C75-8BBD-4C88-91D2-B78966A2AB1A Q46214426-4BEE20DF-F00A-4E34-BF4C-2354791FB652 Q47331095-2A399DE6-D006-4DF7-B3D9-70F9643BB747 Q49587453-C26A3672-5131-4BF9-A0E1-CDA9F1BF93C9 Q49922654-06035907-B54A-4845-8859-C3AF6DC0ED8A

P2860

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women.

http://www.wikidata.org/entity/Q35167137

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Immunogenicity of an inactivat ...... nza vaccine in pregnant women.

@ast

Immunogenicity of an inactivat ...... nza vaccine in pregnant women.

@en

type

label

Immunogenicity of an inactivat ...... nza vaccine in pregnant women.

@ast

Immunogenicity of an inactivat ...... nza vaccine in pregnant women.

@en

prefLabel

Immunogenicity of an inactivat ...... nza vaccine in pregnant women.

@ast

Immunogenicity of an inactivat ...... nza vaccine in pregnant women.

@en

P1433

Q35167137-511C32B9-F1ED-4468-9C29-A6B4F78BC3C6

P1476

Q35167137-6246841F-1DD2-4BDF-B6E0-800FA44E7985

P2093

Q35167137-23FA0C03-E62E-447E-ADD6-05AF0F414718

Q35167137-4BB2DDEA-26D1-48F9-B89B-0111C1AF9DE7

Q35167137-5F8C6341-3E6D-4BF9-8348-4F2254965E39

Q35167137-63581C15-EE36-49A4-BB0C-D4E0C65CD831

Q35167137-6FD05571-8DE9-45D5-A3A7-312B8D30BFAE

Q35167137-7509B65A-3006-4AC1-AF77-1C515C96C824

Q35167137-7839C474-BE04-4A12-BA8C-FD587ABD0C27

Q35167137-79100B9D-A6FB-4783-933C-A6427766826C

Q35167137-941302D4-EA15-4630-ABE4-5DBBCAA2F860

Q35167137-E1E113DC-A568-4F87-9D91-BF4C8456023D

P2860

Q35167137-09AAB7F4-58EB-48BC-B058-96D7B1C7B560

Q35167137-0C5DABEC-4E73-4DE1-BF78-7AA549B063D5

Q35167137-17BD8AEC-1AC8-49B8-B97A-1343BA3C4CD6

Q35167137-18A13CD4-56B2-466B-8585-334CEACF9BE4

Q35167137-1F3C9E2E-70D6-4173-B6FF-93FFD958956D

Q35167137-204B29CA-14C2-4E89-B575-2809D31F57B4

Q35167137-2A7A4DA4-1B96-45E7-9F8D-62C85797A5B6

Q35167137-2FFF4C52-EEF7-4F09-AD34-5ED24FD08217

Q35167137-34AE7689-56DE-4E34-BAC5-D42FA72EAD55

Q35167137-3883BB50-248C-49BB-8B10-5AA5AA8FF879

P304

Q35167137-80C8669D-ACEB-457D-8260-FB39288305ED

P31

Q35167137-4615E798-F2B1-497D-8BC0-F96444A738D5

P356

Q35167137-B3777CFD-E4F9-4A6D-AD13-1B863EE05CB8

P407

Q35167137-81CBCFCD-3A43-439E-99CC-225A877B39F9

P433

Q35167137-AF9085E0-9749-4648-A0E8-0FFD471F5636

P478

Q35167137-BB367327-5F0F-4A47-8B84-854CE4BF46A3

P50

Q35167137-380BFEDE-1965-4148-8293-49F9A8A1437A

Q35167137-8B000363-1B51-46AD-B239-481E59F4F4D9

P577

Q35167137-849A1C3F-D4AA-48E3-8D51-0573EC2FA5C6

P5875

Q35167137-0F7BD97C-44BF-4B07-9F67-5B55B193ACCC

P698

Q35167137-68266A33-D41B-4429-97F0-38B6FC7FF97C

P932

Q35167137-98CAE663-3DAF-4FEA-B6C1-5214E9907F93

P356

P1433

The Journal of Infectious Diseases

P1476

Immunogenicity of an inactivat ...... nza vaccine in pregnant women.

@en

P2093

C Buddy Creech

http://www.w3.org/2001/XMLSchema#string

Carey Rodeheffer Petrie

http://www.w3.org/2001/XMLSchema#string

Diana L Noah

http://www.w3.org/2001/XMLSchema#string

Flor M Munoz

http://www.w3.org/2001/XMLSchema#string

Geeta K Swamy

http://www.w3.org/2001/XMLSchema#string

Lisa A Jackson

http://www.w3.org/2001/XMLSchema#string

Mark Wolff

http://www.w3.org/2001/XMLSchema#string

Raul Artal

http://www.w3.org/2001/XMLSchema#string

Sharon E Frey

http://www.w3.org/2001/XMLSchema#string

Shital M Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California

Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials.

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

H1N1 2009 influenza virus infection during pregnancy in the USA.

Response to a monovalent 2009 influenza A (H1N1) vaccine.

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

A novel influenza A (H1N1) vaccine in various age groups.

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

P304

854-863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIR440

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn M. Edwards

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51578578

http://www.w3.org/2001/XMLSchema#string

P698

21849282

http://www.w3.org/2001/XMLSchema#string

P932

3156926

http://www.w3.org/2001/XMLSchema#string